New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
September 23, 2016 – The FDA announced the approval of Novartis’ Ilaris (canakinumab) for the following indications in adult and pediatric patients.
Download PDF
Return to publications
